Bio-Techne Corporation has announced a strategic collaboration with the Wyss Center for Bio and Neuroengineering (Wyss Geneva) to develop an automated workflow for simultaneous RNA and protein detection in 3D tissue specimens. This partnership aims to advance multiomic spatial biology technologies by enabling high-resolution analysis within intact 3D samples, reducing technical barriers, and simplifying complex processes. The initiative is expected to accelerate drug discovery, improve preclinical research with less reliance on animal models, and foster innovation in biomedical studies by making advanced spatial biology tools more accessible to researchers.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio-Techne Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CG37602) on December 11, 2025, and is solely responsible for the information contained therein.